Hae Jin Kee Selected Research

Messenger RNA (mRNA)

1/2021	Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway.
1/2019	Selective inhibition of histone deacetylase 8 improves vascular hypertrophy, relaxation, and inflammation in angiotensin II hypertensive mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hae Jin Kee Research Topics

Disease

22	Cardiomegaly (Heart Hypertrophy) 01/2023 - 01/2006
15	Hypertension (High Blood Pressure) 01/2022 - 01/2013
14	Fibrosis (Cirrhosis) 12/2023 - 01/2006
13	Hypertrophy 01/2022 - 01/2006
8	Inflammation (Inflammations) 01/2023 - 11/2012
7	Neoplasms (Cancer) 01/2022 - 03/2008
5	Hyperplasia 01/2024 - 11/2011
5	Heart Failure 01/2023 - 12/2017
5	Body Weight (Weight, Body) 01/2023 - 05/2014
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
3	Vascular Calcification 11/2017 - 11/2014
3	Brain Ischemia (Cerebral Ischemia) 01/2006 - 09/2002
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2017 - 04/2010
2	Thrombosis (Thrombus) 04/2015 - 06/2013
2	Neointima 11/2012 - 05/2012
2	Leukemia 07/2012 - 03/2008
2	Ischemia 07/2004 - 09/2002
1	Wounds and Injuries (Trauma) 01/2024
1	Atherosclerosis 01/2021
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2020
1	Myocardial Infarction 01/2020
1	Vascular Remodeling 01/2019

Drug/Important Bio-Agent (IBA)

18	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 01/2006
13	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2006
11	Isoproterenol (Isoprenaline)FDA LinkGeneric 12/2023 - 11/2008
10	Gallic AcidIBA 01/2022 - 11/2014
10	Angiotensin IIIBA 01/2022 - 01/2006
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2011
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2006
5	EnzymesIBA 01/2022 - 01/2011
4	Valproic Acid (Depakote)FDA LinkGeneric 01/2019 - 01/2006
4	Small Interfering RNA (siRNA)IBA 01/2017 - 05/2011
4	Histones (Histone)IBA 09/2015 - 01/2006
4	trichostatin A (A 300)IBA 11/2011 - 01/2006
3	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 01/2023 - 01/2021
3	PCI 34051IBA 01/2022 - 01/2019
3	sulforaphaneIBA 01/2022 - 11/2012
3	CollagenIBA 01/2022 - 10/2016
3	Protein Isoforms (Isoforms)IBA 01/2022 - 03/2008
3	N-propionylprocainamideIBA 01/2021 - 12/2009
3	Collagen Type I (Type I Collagen)IBA 01/2021 - 09/2015
3	2,5-dihydroxybenzoic acid (gentisic acid)IBA 01/2019 - 01/2018
3	Atrial Natriuretic Factor (ANF)IBA 01/2018 - 01/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006 - 09/2002
2	protocatechuic acidIBA 01/2023 - 01/2021
2	Therapeutic UsesIBA 01/2023 - 01/2022
2	C.I. direct red 80IBA 01/2022 - 01/2022
2	p38 Mitogen-Activated Protein KinasesIBA 01/2021 - 01/2016
2	Fibronectins (Fibronectin)IBA 01/2021 - 12/2017
2	Messenger RNA (mRNA)IBA 01/2021 - 01/2019
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2019 - 12/2018
2	Desoxycorticosterone Acetate (DOCA)FDA Link 01/2019 - 01/2013
2	tubastatin AIBA 01/2019 - 09/2015
2	Desoxycorticosterone (Deoxycorticosterone)IBA 01/2019 - 09/2015
2	Acetates (Acetic Acid Esters)FDA Link 01/2019 - 09/2015
2	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2018 - 01/2018
2	MC1568IBA 05/2018 - 11/2016
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018 - 09/2015
2	Connective Tissue Growth FactorIBA 01/2018 - 12/2017
2	AcidsIBA 01/2018 - 12/2017
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 05/2017 - 01/2017
2	Histone Deacetylase 2IBA 01/2017 - 11/2008
2	GoldIBA 01/2017 - 01/2016
2	Phosphotransferases (Kinase)IBA 11/2016 - 08/2006
2	3,3',4,5'-tetrahydroxystilbeneIBA 01/2016 - 05/2014
2	SaltsIBA 09/2015 - 01/2013
2	ChromatinIBA 09/2015 - 07/2012
2	MicroRNAs (MicroRNA)IBA 07/2014 - 08/2013
2	theasinensin AIBA 11/2011 - 12/2009
2	Angiogenesis InhibitorsIBA 07/2004 - 09/2002
1	Platelet-Derived Growth FactorIBA 01/2024
1	Becaplermin (PDGF-BB)FDA Link 01/2024
1	BromidesIBA 01/2024
1	Circular RNAIBA 12/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	CurcuminIBA 01/2022
1	ZincIBA 01/2022
1	syringic acidIBA 01/2022
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 01/2021
1	Nicotine FDA Link 01/2021
1	Polyvinyl Chloride (PVC)IBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	entinostat (MS 275)IBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019
1	Diltiazem (Cardizem)FDA LinkGeneric 12/2018
1	Mitogen-Activated Protein Kinase 3IBA 12/2018
1	Bisoprolol (Concor)FDA LinkGeneric 12/2018
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2018
1	PhytochemicalsIBA 05/2018
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2018
1	Losartan (Cozaar)FDA LinkGeneric 01/2018
1	HesperidinIBA 01/2018
1	Carvedilol (Coreg)FDA LinkGeneric 01/2018
1	AntioxidantsIBA 01/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018

Therapy/Procedure

3	Stents 01/2024 - 06/2013
1	Denervation 01/2020
1	Therapeutics 05/2018